273 related articles for article (PubMed ID: 33172936)
21. Extreme Incidence of Skin Cancer in Kidney and Liver Transplant Recipients Living with High Sun Exposure.
Plasmeijer EI; Jiyad Z; Way M; Marquart L; Miura K; Campbell S; Isbel N; Fawcett J; Ferguson LE; Davis M; Whiteman DC; Soyer HP; O'Rourke P; Green AC
Acta Derm Venereol; 2019 Sep; 99(10):929-930. PubMed ID: 31197384
[No Abstract] [Full Text] [Related]
22. [Risk factors of non melanoma skin cancers in kidney transplant patients].
Sułowicz J; Wojas-Pelc A; Ignacak E; Betkowska-Prokop A; Kuzniewski M; Sułowicz W
Przegl Lek; 2014; 71(1):19-25. PubMed ID: 24712264
[TBL] [Abstract][Full Text] [Related]
23. Higher mycophenolate dosage is associated with an increased risk of squamous cell carcinoma in kidney transplant recipients.
Shao EX; Betz-Stablein B; Marquat L; Campbell S; Isbel N; Green AC; Plasmeijer EI
Transpl Immunol; 2022 Dec; 75():101698. PubMed ID: 35988897
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region.
Bernat García J; Morales Suárez-Varela M; Vilata JJ; Marquina A; Pallardó L; Crespo J
Acta Derm Venereol; 2013 Jul; 93(4):422-7. PubMed ID: 23303600
[TBL] [Abstract][Full Text] [Related]
25. Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers.
Zamoiski RD; Yanik E; Gibson TM; Cahoon EK; Madeleine MM; Lynch CF; Gustafson S; Goodman MT; Skeans M; Israni AK; Engels EA; Morton LM
Cancer Res; 2017 Aug; 77(15):4196-4203. PubMed ID: 28615224
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and risk factors for multiple squamous cell carcinomas in a cohort of organ transplant recipients from northern Italy: a single center study.
Zavattaro E; Veronese F; Airoldi C; DI Cristo N; Savoia P
Ital J Dermatol Venerol; 2023 Oct; 158(5):379-387. PubMed ID: 37916398
[TBL] [Abstract][Full Text] [Related]
27. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
[TBL] [Abstract][Full Text] [Related]
28. Incidence of nonmelanoma skin cancer after human organ transplantation: single-center experience in Hungary.
Fekecs T; Kádár Z; Battyáni Z; Kalmár-Nagy K; Szakály P; Horváth OP; Wéber G; Ferencz A
Transplant Proc; 2010; 42(6):2333-5. PubMed ID: 20692474
[TBL] [Abstract][Full Text] [Related]
29. Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients.
Funk-Debleds P; Ducroux E; Guillaud O; Ursic-Bedoya J; Decullier E; Vallin M; Euvrard S; Pageaux GP; Boillot O; Dumortier J
J Am Acad Dermatol; 2018 Jul; 79(1):84-91. PubMed ID: 29307647
[TBL] [Abstract][Full Text] [Related]
30. Skin cancer following kidney transplantation: a single-center experience.
Karczewski M; Stronka M; Karczewski J; Wiktorowicz K
Transplant Proc; 2011 Dec; 43(10):3760-1. PubMed ID: 22172842
[TBL] [Abstract][Full Text] [Related]
31. A dedicated dermatology clinic for renal transplant recipients: first 5 years of a New Zealand experience.
Maurice PD; Fenton T; Cross N; Thomson IA; Rennie SC; van Rij AM
N Z Med J; 2013 Feb; 126(1369):27-33. PubMed ID: 23463107
[TBL] [Abstract][Full Text] [Related]
32. Pathways from Diagnosis to Death from Keratinocyte Cancer in Kidney Transplant Recipients.
Shao EX; Khosrotehrani K; Campbell S; Isbel N; Green A
Dermatology; 2022; 238(6):1036-1043. PubMed ID: 35439759
[TBL] [Abstract][Full Text] [Related]
33. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation.
Euvrard S; Kanitakis J; Pouteil-Noble C; Dureau G; Touraine JL; Faure M; Claudy A; Thivolet J
J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):222-9. PubMed ID: 7622649
[TBL] [Abstract][Full Text] [Related]
34. Association between Human Leukocyte Antigen Type and Keratinocyte Carcinoma Risk in Renal Transplant Recipients.
Kim Y; Wojciechowski D; Pattanayak V; Lee H; Asgari MM
J Invest Dermatol; 2020 May; 140(5):995-1002. PubMed ID: 31669059
[TBL] [Abstract][Full Text] [Related]
35. In Brief: Hydrochlorothiazide and skin cancer.
Med Lett Drugs Ther; 2020 Nov; 62(1611):177. PubMed ID: 33429413
[No Abstract] [Full Text] [Related]
36. Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis.
Asgari MM; Tsai AL; Avalos L; Sokil M; Quesenberry CP
JAMA Dermatol; 2020 Oct; 156(10):1066-1073. PubMed ID: 32785626
[TBL] [Abstract][Full Text] [Related]
37. Polygenic Risk Scores Allow Risk Stratification for Keratinocyte Cancer in Organ-Transplant Recipients.
Seviiri M; Law MH; Ong JS; Gharahkhani P; Nyholt DR; Olsen CM; Whiteman DC; MacGregor S
J Invest Dermatol; 2021 Feb; 141(2):325-333.e6. PubMed ID: 32615124
[TBL] [Abstract][Full Text] [Related]
38. Azathioprine and Risk of Skin Cancer in Organ Transplant Recipients: Systematic Review and Meta-Analysis.
Jiyad Z; Olsen CM; Burke MT; Isbel NM; Green AC
Am J Transplant; 2016 Dec; 16(12):3490-3503. PubMed ID: 27163483
[TBL] [Abstract][Full Text] [Related]
39. Comparison of skin cancers in liver and renal transplant recipients: Results of a prospective study in an Australian tertiary referral centre.
Ge L; Chee SN; Robledo KP; Lowe P
Australas J Dermatol; 2018 Nov; 59(4):291-296. PubMed ID: 29292515
[TBL] [Abstract][Full Text] [Related]
40. The Risk of Cutaneous Squamous Cell Carcinoma Among Patients with Type 2 Diabetes Receiving Hydrochlorothiazide: A Cohort Study.
de Haan-Du J; Landman GWD; Groenier KH; Vissers PAJ; Louwman MWJ; Kleefstra N; de Bock GH
Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2114-2121. PubMed ID: 34493493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
